FORTE, DORIAN
 Distribuzione geografica
Continente #
AS - Asia 2.018
NA - Nord America 2.007
EU - Europa 1.580
AF - Africa 135
SA - Sud America 124
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.870
Nazione #
US - Stati Uniti d'America 1.972
SG - Singapore 621
CN - Cina 562
IT - Italia 480
VN - Vietnam 347
GB - Regno Unito 265
SE - Svezia 192
DE - Germania 188
HK - Hong Kong 158
IN - India 108
KR - Corea 100
BR - Brasile 91
NL - Olanda 70
FI - Finlandia 64
IE - Irlanda 61
FR - Francia 55
RU - Federazione Russa 50
TG - Togo 47
CI - Costa d'Avorio 39
BG - Bulgaria 29
TR - Turchia 25
CA - Canada 23
BE - Belgio 21
JO - Giordania 20
JP - Giappone 20
ZA - Sudafrica 19
EE - Estonia 18
ID - Indonesia 17
UA - Ucraina 17
CH - Svizzera 15
AT - Austria 13
IR - Iran 12
PL - Polonia 12
NG - Nigeria 10
EC - Ecuador 9
ES - Italia 9
CL - Cile 8
MX - Messico 8
SC - Seychelles 8
AR - Argentina 7
BD - Bangladesh 6
LT - Lituania 6
TH - Thailandia 4
TW - Taiwan 4
UY - Uruguay 4
AU - Australia 3
IQ - Iraq 3
MA - Marocco 3
PT - Portogallo 3
GH - Ghana 2
HU - Ungheria 2
IL - Israele 2
KE - Kenya 2
MY - Malesia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BO - Bolivia 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
LV - Lettonia 1
PK - Pakistan 1
PS - Palestinian Territory 1
PY - Paraguay 1
SN - Senegal 1
SV - El Salvador 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.870
Città #
Singapore 431
Ashburn 306
Chandler 245
Southend 212
Hefei 156
Hong Kong 155
Fairfield 125
Bologna 105
Dong Ket 105
Seoul 99
Beijing 88
Ann Arbor 81
Santa Clara 80
Ho Chi Minh City 72
Wilmington 69
Dublin 61
Princeton 60
Seattle 55
Houston 52
Milan 50
Hanoi 49
Lomé 47
Woodbridge 47
Cambridge 46
Boardman 45
Dallas 42
Helsinki 40
Abidjan 39
Cornaredo 32
Los Angeles 28
Sofia 27
New York 25
Redmond 24
Turin 24
Bremen 23
Hyderabad 23
Berlin 21
Munich 21
Westminster 21
Amman 20
Brussels 19
Tokyo 19
Burdur 18
Nanjing 18
Bengaluru 17
Jinan 17
Redondo Beach 17
Rome 17
Buffalo 16
Lappeenranta 15
Padova 15
San Jose 14
Shenyang 14
Frankfurt am Main 13
Jakarta 13
Nuremberg 12
San Diego 12
São Paulo 11
Abeokuta 10
London 10
Redwood City 10
Shanghai 10
Bern 9
Florence 9
Hangzhou 9
Medford 9
Norwalk 9
Saint Petersburg 9
Taiyuan 9
Tianjin 9
Toronto 9
Changsha 8
Falkenstein 8
Fremont 8
San Francisco 8
Stockholm 8
Turku 8
Boston 7
Guangzhou 7
Nanchang 7
Orem 7
Warsaw 7
Council Bluffs 6
Falls Church 6
Montreal 6
Quận Bình Thạnh 6
Canzo 5
Cesena 5
Des Moines 5
Haiphong 5
Perugia 5
Shijiazhuang 5
Vienna 5
Xi'an 5
Zhengzhou 5
Abano Terme 4
Atlanta 4
Biên Hòa 4
Boydton 4
Bühl 4
Totale 3.821
Nome #
Human cord blood-derived platelet lysate enhances the therapeutic activity of adipose-derived mesenchymal stromal cells isolated from Crohn's disease patients in a mouse model of colitis 286
Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia 228
Circulating calreticulin is increased in myelofibrosis: Correlation with interleukin-6 plasma levels, bone marrow fibrosis, and splenomegaly 226
Disease-specific derangement of circulating endocannabinoids and n-acylethanolamines in myeloproliferative neoplasms 188
CIRCULATING PLATELET AND MEGAKARYOCYTE-DERIVED MICROPARTICLES OF JAK2V617F MUTATED PATIENTS WITH MYELOFIBROSIS ARE DISREGULATED: A NOVEL LIQUID BIOPSY TOOL OF RESPONSE TO RUXOLITINIB? 182
Distinct profile of CD34+ cells and plasma-derived extracellular vesicles from triple-negative patients with Myelofibrosis reveals potential markers of aggressive disease 176
CIRCULATING CD34+ STEM/PROGENITOR CELLS FROM TRIPLE NEGATIVE PATIENTS WITH MYELOFIBROSIS SHOW DIFFERENT NUMBER, GENE EXPRESSION PROFILE AND IN VITRO RESPONSE TO INFLAMMATORY STIMULI AS COMPARED WITH THE JAK2(V617F) MUTATED COUNTERPARTS 173
Mobilized Peripheral Blood versus Cord Blood: Insight into the distinct role of proinflammatory cytokines on survival, clonogenic ability, and migration of CD34+ cells 172
STUDIO DELLA FUNZIONE E DEL PROFILO DEI MICRORNA IN MICROPARTICELLE CIRCOLANTI ISOLATE DA PAZIENTI ‘TRIPLI NEGATIVI’ E JAK2V617F MUTATI CON MIELOFIBROSI 170
Circulating Platelet Vs Megakaryocyte-Derived Microparticles Identify Myelofibrosis Patients with JAK2V617F Mutation, High Disease Burden and Ruxolitinib Response 167
The more, the better: "Do the right thing" for natural killer immunotherapy in acute myeloid leukemia 165
Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis 162
The relevance of a low JAK2V617F allele burden in clinical practice: a monocentric study 160
Circulating extracellular particles from severe COVID-19 patients show altered profiling and innate lymphoid cell-modulating ability 157
Crucial factors of the inflammatory microenvironment (IL-1β/ TNF-α/TIMP-1) promote the maintenance of the malignant hemopoietic clone of myelofibrosis: an in vitro study 156
Bone Marrow Mesenchymal Stem Cells Support Acute Myeloid Leukemia Bioenergetics and Enhance Antioxidant Defense and Escape from Chemotherapy 156
The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling 154
Mutations in JAK2 and Calreticulin genes are associated with specific alterations of the immune system in myelofibrosis 152
Denatonium as a Bitter Taste Receptor Agonist Modifies Transcriptomic Profile and Functions of Acute Myeloid Leukemia Cells 151
Crucial Factors of the Inflammatory Microenvironment (IL-1 beta/TNF-alpha/TIMP-1) Promote Maintenance of the Malignant Hemopoietic Clone of Myelofibrosis By Stimulating the in Vitro Survival/Proliferation/Migration of Circulating CD34+ stem/Progenitor Cells 150
Corrigendum: Denatonium as a Bitter Taste Receptor Agonist Modifies Transcriptomic Profile and Functions of Acute Myeloid Leukemia Cells (Front. Oncol, (2020), 10, (1225), 10.3389/fonc.2020.01225) 150
TOWARD THE IDENTIFICATION OF A MICRORNA-BASED SIGNATURE OF CIRCULATING MICROPARTICLES FROM TRIPLE NEGATIVE AND JAK2(V617F) MUTATED PATIENTS WITH MYELOFIBROSIS 149
Parallel single-cell metabolic analysis and extracellular vesicle profiling reveal vulnerabilities with prognostic significance in acute myeloid leukemia 146
The tissue inhibitor of metalloproteinases 1 increases the clonogenic efficiency of human hematopoietic progenitor cells through CD63/PI3K/Akt signaling 145
Platelet lysate enhances the therapeutic activity of Adipose Derived Mesenchymal stromal cells isolated from Crohn disease patients in a novel Mouse model of Colitis 141
The “vesicular intelligence” strategy of blood cancers 125
The Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) Regulates the Function and Migration of Leukemic Blasts through CD63/PI3K/AKT/P21 Axis 124
INFLAMMATORY PATHWAYS IN THE BONE MARROW: ROLE OF TIMP-1 IN HEMATOPOIETIC STEM/PROGENITOR CELLS AND LEUKEMIA 118
A venetoclax and azacitidine bridge-to-transplant strategy for NPM1-mutated acute myeloid leukaemia in molecular failure 118
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches 116
Ex vivo characterization of acute myeloid leukemia patients undergoing hypomethylating agents and venetoclax regimen reveals a venetoclax-specific effect on non-suppressive regulatory T cells and bona fide PD-1+TIM3+ exhausted CD8+ T cells 111
The role of circulating monocytes and JAK inhibition in the infectious-driven inflammatory response of myelofibrosis 111
Tracking Response and Resistance in Acute Myeloid Leukemia through Single-Cell DNA Sequencing Helps Uncover New Therapeutic Targets 109
Tamoxifen for the treatment of myeloproliferative neoplasms: A Phase II clinical trial and exploratory analysis 106
Risk factors for progression to blast phase and outcome in 589 patients with myelofibrosis treated with ruxolitinib: Real-world data 102
Emerging bone marrow microenvironment‐driven mechanisms of drug resistance in acute myeloid leukemia: Tangle or chance? 102
Updates on the hematologic tumor microenvironment and its therapeutic targeting 98
Bone marrow mesenchymal stromal cells support translation in refractory acute myeloid leukemia 87
KAT2A complexes ATAC and SAGA play unique roles in cell maintenance and identity in hematopoiesis and leukemia 85
IDENTIFICATION OF POLYCYTHEMIA VERA-SPECIFIC BIOMARKERS OF OUTCOME BY NOVEL MULTIDIMENSIONAL ANALYSIS APPROACHES 73
Single-Cell Metabolic Profiling Integrated with Extracellular Vesicle Analysis Reveals Novel Metabolic Vulnerabilities and Prognostic Biomarkers in Acute Myeloid Leukemia 49
Extracellular Vesicle-Based Liquid Biopsy Shows Clinical Relevance and Reveals Links with Single-Cell Metabolic Signature in Acute Myeloid Leukemia 44
Clinical Implications of Plasma-Derived Extracellular Vesicles in Myeloproliferative Neoplasms: Unveiling Inflammatory Potential and Biomarkers for Cancer Treatment 39
PICK A WORD: HOW EXTRACELLULAR VESICLES DICTATE THE NORMAL AND LEUKEMIC HEMATOPOIETIC LANDSCAPE 27
Leukemic Stem Cells Co-Opt Normal Bone Marrow Niches As a Source of Energy and Antioxidant Defence 14
null 2
Totale 6.022
Categoria #
all - tutte 17.265
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.265


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021333 0 0 0 0 0 0 24 17 53 19 20 200
2021/2022692 26 28 46 60 60 27 14 40 28 73 156 134
2022/2023897 115 139 52 120 51 79 15 43 156 21 56 50
2023/2024342 22 42 14 49 22 55 19 22 17 26 38 16
2024/20251.265 83 106 112 87 124 69 88 69 76 102 96 253
2025/20261.649 332 375 245 216 289 156 36 0 0 0 0 0
Totale 6.022